Contineum Therapeutics, Inc. Class A Common Stock ( CTNM) - Key Metrics
CTNM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.49 | -$0.42 | -$0.42 |
| 2025Q3 | ? | -$0.45 | -$0.43 | -$0.44 |
| 2025Q2 | ? | -$0.62 | -$0.60 | -$0.61 |
| 2025Q1 | ? | -$0.62 | -$0.56 | -$0.56 |
CTNM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -5.82 |
| 2025Q3 | ? | -6.46 |
| 2025Q2 | ? | -1.60 |
| 2025Q1 | ? | -2.82 |
CTNM
Price: $12.42
52 week price:
Earnings Per Share: -1.94 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 429.6 million